Solid forms and formulations of (s)-4-(8-amino-3-(1 -(but-2-ynoyl)pyrrolidin-2- yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
MYPI2025000457A0Undetermined Publication Date: 2017-01-02ACERTA PHARMA BV
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025000457
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-12-28
- Filing Date
- 2016-07-01
- Publication Date
- 2017-01-02
Abstract
In some embodiments, the invention relates to crystalline solid forms, including polymorphs, hydrates, and salt forms, of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide. In some embodiments, the invention also relates to pharmaceutical compositions containing the crystalline solid forms, and methods for treating conditions or disorders by administering to a subject a pharmaceutical composition that includes the forms, including pharmaceutical compositions and methods for overcoming the effects of acid reducing agents. FIG. 1
Need to check novelty before this filing date? Find Prior Art
